Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 97.48 USD -0.03%
Market Cap: 3.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+98%
Revenue
Forecast
+13%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

AMED Price Targets Summary
Amedisys Inc

Wall Street analysts forecast AMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMED is 102.85 USD with a low forecast of 101 USD and a high forecast of 106.05 USD.

AMED Lowest Forecast
Wall Street Target
101 USD
4% Upside
AMED Average Forecast
Wall Street Target
102.85 USD
6% Upside
AMED Highest Forecast
Wall Street Target
106.05 USD
9% Upside
Lowest
Price Target
101 USD
4% Upside
Average
Price Target
102.85 USD
6% Upside
Highest
Price Target
106.05 USD
9% Upside
Amedisys Inc Competitors:
Price Targets
IDX
Integral Diagnostics Ltd
19% Upside
OPCH
Option Care Health Inc
30% Upside
ADUS
Addus Homecare Corp
27% Upside
002044
Meinian Onehealth Healthcare Holdings Co Ltd
36% Upside
IDX
Integral Diagnostics Ltd
19% Upside
OPCH
Option Care Health Inc
30% Upside
ADUS
Addus Homecare Corp
27% Upside
002044
Meinian Onehealth Healthcare Holdings Co Ltd
36% Upside
4544
H.U. Group Holdings Inc
5% Downside
SBC
SBC Medical Group Holdings Inc
17% Upside
526783
Dr Agarwal's Eye Hospital Ltd
90% Downside
WGS
GeneDx Holdings Corp
20% Upside

Revenue
Forecast

Revenue Estimate
Amedisys Inc

For the last 8 years the compound annual growth rate for Amedisys Inc's revenue is 6%. The projected CAGR for the next 3 years is 6%.

6%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amedisys Inc

For the last 8 years the compound annual growth rate for Amedisys Inc's operating income is 17%. The projected CAGR for the next 3 years is 12%.

17%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amedisys Inc

For the last 8 years the compound annual growth rate for Amedisys Inc's net income is 2%. The projected CAGR for the next 3 years is 58%.

2%
Past Growth
58%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

See Also

Summary
AMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMED stock valuation using valuation multiples.
Wall Street Estimates
AMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMED's stock price target?
Price Target
102.85 USD

According to Wall Street analysts, the average 1-year price target for AMED is 102.85 USD with a low forecast of 101 USD and a high forecast of 106.05 USD.

What is Amedisys Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Amedisys Inc's revenue is 6%. The projected CAGR for the next 3 years is 6%.

What is Amedisys Inc's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Amedisys Inc's operating income is 17%. The projected CAGR for the next 3 years is 12%.

What is Amedisys Inc's Net Income forecast?
Projected CAGR
58%

For the last 8 years the compound annual growth rate for Amedisys Inc's net income is 2%. The projected CAGR for the next 3 years is 58%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 268,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.